SCHEMBL9899641

SCHEMBL9899641

CCCCC[C@H]1CC[C@H]([C@H]2CC[C@H]([C@H]3CC[C@H](c4ccc(OCC)c(F)c4F)CC3)CO2)CC1

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9899407 1.00 GAA (0.31) GAAMAPT
SCHEMBL9899412 1.00 GAA (0.31) GAAMAPT
SCHEMBL9899408 1.00 GAA (0.31) GAAMAPT
SCHEMBL9899409 1.00 GAA (0.31) GAAMAPT
SCHEMBL9899634 1.00 GAA (0.31) GAAMAPT
SCHEMBL9899637 1.00 GAA (0.31) GAAMAPT
SCHEMBL9899108 0.95 GAA (0.30) GAAMAPT
SCHEMBL9927645 0.95 GAA (0.30) GAAMAPT
SCHEMBL9899109 0.95 GAA (0.30) GAAMAPT
SCHEMBL9927504 0.95 GAA (0.32) GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11834622-B2 Fragrance compositions containing norbornene derivatives for personal care products PROMERUS, LLC (US) 2023-12-05 US claimed
US-20230146062-A1 FRAGRANCE COMPOSITIONS CONTAINING NORBORNENE DERIVATIVES FOR PERSONAL CARE PRODUCTS PROMERUS, LLC (US) 2023-05-11 US claimed
WO-2021146495-A1 FRAGRANCE COMPOSITIONS CONTAINING NORBORNENE DERIVATIVES FOR PERSONAL CARE PRODUCTS PROMERUS, LLC (US) 2021-07-22 WO claimed
US-20210214642-A1 FRAGRANCE COMPOSITIONS CONTAINING NORBORNENE DERIVATIVES FOR PERSONAL CARE PRODUCTS PROMERUS, LLC (US) 2021-07-15 US claimed
EP-3824054-A2 FRAGRANCE COMPOSITIONS CONTAINING NORBORNENE DERIVATIVES Promerus, LLC (US) 2021-05-26 EP claimed
US-10591818-B2 Nadic anhydride polymers and photosensitive compositions derived therefrom PROMERUS, LLC (US) 2020-03-17 US claimed
WO-2020018485-A2 FRAGRANCE COMPOSITIONS CONTAINING NORBORNENE DERIVATIVES PROMERUS, LLC (US) 2020-01-23 WO claimed
WO-2018022952-A1 NADIC ANHYDRIDE POLYMERS AND PHOTOSENSITIVE COMPOSITIONS DERIVED THEREFROM PROMERUS, LLC (US) 2018-02-01 WO claimed
US-20180030189-A1 NADIC ANHYDRIDE POLYMERS AND PHOTOSENSITIVE COMPOSITIONS DERIVED THEREFROM PROMERUS, LLC (US) 2018-02-01 US claimed
US-11834622-B2 Fragrance compositions containing norbornene derivatives for personal care products PROMERUS, LLC (US) 2023-12-05 US disclosed
US-20230146062-A1 FRAGRANCE COMPOSITIONS CONTAINING NORBORNENE DERIVATIVES FOR PERSONAL CARE PRODUCTS PROMERUS, LLC (US) 2023-05-11 US disclosed
US-11584899-B2 Fragrance compositions containing norbornene derivatives for personal care products PROMERUS, LLC (US) 2023-02-21 US disclosed
US-11572528-B2 Fragrance compositions containing norbornene derivatives PROMERUS, LLC (US) 2023-02-07 US disclosed
WO-2021146495-A1 FRAGRANCE COMPOSITIONS CONTAINING NORBORNENE DERIVATIVES FOR PERSONAL CARE PRODUCTS PROMERUS, LLC (US) 2021-07-22 WO disclosed
US-8829087-B2 Transparent layer forming polymer PROMERUS, LLC (US) 2014-09-09 US disclosed
EP-2651996-A1 TRANSPARENT LAYER FORMING POLYMER Promerus, LLC (US) 2013-10-23 EP disclosed
EP-2468740-A1 TETRAHYDROPYRAN COMPOUNDS, LIQUID CRYSTAL COMPOSITIONS AND LIQUID CRYSTAL DISPLAY ELEMENTS JNC Corporation (JP) 2012-06-27 EP disclosed
WO-2012082705-A1 TRANSPARENT LAYER FORMING POLYMER PROMERUS LLC (US) 2012-06-21 WO disclosed
US-20120145958-A1 TETRAHYDROPYRAN COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC PETROCHEMICAL CORPORATION (JP) 2012-06-14 US disclosed
US-20120149815-A1 Transparent Layer Forming Polymer PROMERUS LLC (US) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230146062-A1 FRAGRANCE COMPOSITIONS CONTAINING NORBORNENE DERIVATIVES FOR PERSONAL CARE PRODUCTS POLR1C, CYP1B1, CUTA GAA 4752/4885MAPT 3994/4885
US-11584899-B2 Fragrance compositions containing norbornene derivatives for personal care products POLR1C, CYP1B1, CUTA GAA 4752/4885MAPT 3994/4885
US-20120145958-A1 TETRAHYDROPYRAN COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE DRD1, CCND1, CCND2 GAA 4777/4885MAPT 3281/4885
US-11834622-B2 Fragrance compositions containing norbornene derivatives for personal care products POLR1C, CYP1B1, CUTA GAA 4752/4885MAPT 3994/4885
US-20210214642-A1 FRAGRANCE COMPOSITIONS CONTAINING NORBORNENE DERIVATIVES FOR PERSONAL CARE PRODUCTS POLR1C, CYP1B1, CUTA GAA 4752/4885MAPT 3994/4885
US-11572528-B2 Fragrance compositions containing norbornene derivatives TAS2R1, TAS2R5, TAS1R1 GAA 4312/4885MAPT 3384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.